Logotype for Exasol AG

Exasol (EXL) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Exasol AG

Q2 2025 earnings summary

23 Nov, 2025

Executive summary

  • Revenue grew 10.8% year-over-year to EUR 21.5 million in H1 2025, with EBITDA at EUR 2.0 million and net income at EUR 1.4 million, reflecting strong profitable growth.

  • Strategic focus on regulated verticals (financial services, healthcare, utilities, public sector) led to 69% of ARR from these sectors, with 28% ARR growth in focus verticals.

  • Major upsell and renewal with Finanz Informatik doubled ARR from this key customer, marking the largest contract in company history.

  • Hardware and services contributed nearly EUR 2.9 million in H1 revenue, deepening customer relationships and supporting long-term growth.

  • Net liquidity increased to EUR 22.2 million, supporting ongoing investments and operational flexibility.

Financial highlights

  • ARR at EUR 38.7 million, down 2.8% year-over-year, mainly due to elevated churn in non-focus verticals, especially retail.

  • EBITDA improved from EUR 0.7 million to EUR 2.0 million year-over-year; net income rose from EUR -0.3 million to EUR 1.4 million.

  • Gross profit for H1 2025 was EUR 18.9 million, with recurring revenue at EUR 18.6 million and non-recurring revenue at EUR 2.9 million.

  • Personnel expenses decreased by EUR 1.8 million year-over-year; total costs reduced by EUR 2.3 million.

  • Net liquidity rose by EUR 7.2 million to EUR 22.2 million compared to end of Dec 2024.

Outlook and guidance

  • Guidance maintained for mid-single-digit percentage growth in ARR and revenue for FY 2025.

  • EBITDA guidance of EUR 3–4 million for the year, with profitability supported by recurring software and hardware/service deals.

  • H2 expected to see lower churn and strong upsell momentum in focus sectors, targeting at least EUR 4–4.5 million net ARR addition.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more